Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 3Gastrointestinal 3Plasma cell 2Head & Neck 2CNS 2Breast 2

Conditions

Breast Neoplasms 2Peripheral Nervous System Diseases 1Depression 1Anxiety Disorders 1Acute Pain 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Minocycline × Breast × Clear all
NCT02203552 2025-01-08

Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Completed
56 enrolled 9 charts
Breast

Anxiety Disorders, Breast Neoplasms, Depression

NCT02297412 2022-01-31

Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel

Academic and Community Cancer Research United

Phase 2 Completed
47 enrolled 9 charts
Breast

Breast Neoplasms, Peripheral Nervous System Diseases, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡